Clinical Trial Update: Composite Probiotics Stabilize Lipid Metabolism in Chronic Hepatitis B Patients:A Clinical Trial [NA]

View source ↗

Summary

Clinical trial update reports that composite probiotics stabilized lipid metabolism in patients with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Composite Probiotics

Snippet

Sponsor: Wecare Probiotics Co., Ltd. | Conditions: Chronic Hepatitis B | NA | Status: COMPLETED